| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/18/2000 | CA2350071A1 Use of propionyl l-carnitine for the preparation of a medicament capable of inducing apoptosis |
| 05/18/2000 | CA2349951A1 Platelet-derived growth factor d, dna coding therefor, and uses thereof |
| 05/18/2000 | CA2349904A1 Crf receptor antagonists and methods relating thereto |
| 05/18/2000 | CA2349761A1 Corticosteroid synthesis-associated genes |
| 05/18/2000 | CA2349498A1 Methods and compositions for treating or preventing peripheral neuropathies |
| 05/18/2000 | CA2348934A1 Phosphinate peptide analogs for the treatment of fibrotic disorders |
| 05/18/2000 | CA2348885A1 Combination therapy of angiotensin converting enzyme inhibitor and aldosterone antagonist for reducing morbidity and mortality from cardiovascular disease |
| 05/18/2000 | CA2347916A1 Inhibition of the formation of vascular hyperpermeability |
| 05/18/2000 | CA2345620A1 Products and methods for brachytherapy |
| 05/18/2000 | CA2345459A1 Bicyclic signal transduction inhibitors, compositions containing them & uses thereof |
| 05/17/2000 | EP1001023A2 Frizzled-4, a putative Wnt-receptor |
| 05/17/2000 | EP1000938A1 Heterocyclic compounds as pharmaceuticals |
| 05/17/2000 | EP1000930A2 Tachykinin antagonists |
| 05/17/2000 | EP1000621A2 Use of 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz (CD) indoles for treating motion sickness and vomiting |
| 05/17/2000 | EP1000166A2 Inhibitors of cell-cycle progression and uses related thereto |
| 05/17/2000 | EP1000145A1 Heart and skeleton muscle specific nucleic acid, the production and use thereof |
| 05/17/2000 | EP1000085A1 Treatment of insulin resistance with growth hormone secretagogues |
| 05/17/2000 | EP1000079A1 New formulation |
| 05/17/2000 | EP1000067A1 Thiazolobenzoheterocycles, preparation and medicines containing same |
| 05/17/2000 | EP1000066A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use |
| 05/17/2000 | EP1000057A1 Pyridyl- and pyrimidyl-heterocyclic compounds inhibiting oxido squalene-cyclase |
| 05/17/2000 | EP1000055A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS |
| 05/17/2000 | EP1000051A1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/17/2000 | EP1000048A1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 05/17/2000 | EP1000044A1 Benzothia(oxa)diazol derivatives and their use as endothelin-receptor antagonists |
| 05/17/2000 | EP1000041A1 1,3-diaza- heterocycles and their use as nitric oxide synthase inhibitors |
| 05/17/2000 | EP1000035A1 Substituted 6-phenylphenanthridines |
| 05/17/2000 | EP1000034A1 Substituted 6-alkylphenanthridines |
| 05/17/2000 | EP1000031A1 Vitronectin receptor antagonist |
| 05/17/2000 | EP1000027A1 Thermodynamically stable modification of 1-(4-carbazolyloxy)-3- 2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it |
| 05/17/2000 | EP1000017A1 Il-8 receptor antagonists |
| 05/17/2000 | EP1000015A1 Bicyclic metabotropic glutamate receptor ligands |
| 05/17/2000 | EP1000008A1 Novel thyroid receptor ligands and method |
| 05/17/2000 | EP0999854A1 Switchable viscoelastic systems containing galactomannan polymers and borate |
| 05/17/2000 | EP0999843A1 Pharmaceutical compositions containing vitamin d and calcium, their preparation and therapeutic use |
| 05/17/2000 | EP0999842A1 Novel substituted imidazole compounds |
| 05/17/2000 | EP0999841A1 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine |
| 05/17/2000 | EP0999839A1 Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches |
| 05/17/2000 | EP0999836A1 A pharmaceutical composition active in reducing production of mcp-1 protein |
| 05/17/2000 | EP0999832A1 Composition comprising l-carnitine or an alkanoyl l-carnitine and long-chain alkanols |
| 05/17/2000 | EP0770066B1 Serotonin 5-ht 1a and dopamin d2 receptor ligands |
| 05/17/2000 | EP0726768B1 Use of nitric oxide releasing compounds for the manufacture of a medicament for protection in ischemia reperfusion injury |
| 05/17/2000 | EP0601106B1 Morphogen-induced modulation of inflammatory response |
| 05/17/2000 | CN1253565A Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines |
| 05/17/2000 | CN1253561A Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3', 5'-monophosphate phosphodiesterase (cGMP PDE5) for treatment of sexual dysfunction |
| 05/17/2000 | CN1253560A Sulfonamides for treatment of endothelin-mediated disorders |
| 05/17/2000 | CN1253559A Sulfonyl divalent aryl alpha-hydroxamic acid compounds |
| 05/17/2000 | CN1253555A Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same |
| 05/17/2000 | CN1253553A Substituted phenyl derivatives, their preparation and use |
| 05/17/2000 | CN1253545A Aryl sulfonamides and analogues thereof and their use in treatment of neurodegenerative diseases |
| 05/17/2000 | CN1253502A Method of using cyclooxygenase-2 inhibitors in prevention of cardiovascular disorders |
| 05/17/2000 | CN1253501A IL-8 receptor antagonists |
| 05/17/2000 | CN1253474A Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 05/17/2000 | CN1253007A Medicine for treating piles and its preparing process |
| 05/17/2000 | CN1052398C Pharmaceutical spheroid formulation |
| 05/16/2000 | US6063964 5-hydroxymethyl-2-aminotetralins as cardiovascular agents |
| 05/16/2000 | US6063812 Angiogenesis inhibitors, antiarthritic agents and anticarcinogenic agents plus synthesis |
| 05/16/2000 | US6063810 2-aminoethyl-benzofuran derivatives, preparation thereof and therapeutical use thereof |
| 05/16/2000 | US6063807 Cyclo-oxygenase inhibitor and amidine derivatives salts, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing said salts |
| 05/16/2000 | US6063797 γ-RAR antagonist ligand or α-RAR agonist ligand as an apoptosis inhibitor |
| 05/16/2000 | US6063796 Heterocyclic compounds of piperidine |
| 05/16/2000 | US6063788 Treatmrnt of artheriosclerosis |
| 05/16/2000 | US6063784 Heteroaryloxyethylamines, method of preparation, application as medicine and pharmaceutical compositions containing them |
| 05/16/2000 | US6063620 Type I angiotensin II receptor specific monoclonal antibodies and hybridomas |
| 05/16/2000 | US6063609 Expression vector comprising an enzymatic protein; for use as diagnostic tools as well as antiarthritic, antiproliferative, anticarcinogenic, antitumor and antiinflammatory agents |
| 05/16/2000 | US6063407 Treatment of vascular thrombosis and restenosis with inhaled nitric oxide |
| 05/16/2000 | CA2215020C Tetrazolyl-substituted quinuclidines as substance p antagonists |
| 05/16/2000 | CA2060865C Stable solid 2-octynyl adenosine and process for producing the same |
| 05/16/2000 | CA1340994C Treatment of conditions and disease |
| 05/13/2000 | CA2289327A1 An anti-edema agent |
| 05/11/2000 | WO2000026399A2 Method for the production of quercetin and isoquercetin derivatives |
| 05/11/2000 | WO2000026395A2 Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors |
| 05/11/2000 | WO2000026372A1 Myosin heavy chain homolog |
| 05/11/2000 | WO2000026348A2 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity |
| 05/11/2000 | WO2000026252A1 Compounds with growth hormone releasing properties |
| 05/11/2000 | WO2000026245A2 Human membrane transport proteins |
| 05/11/2000 | WO2000026243A2 Transmembrane 4 proteins |
| 05/11/2000 | WO2000026239A2 $i(chlamydia) antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | WO2000026227A1 Ldl related protein and uses thereof |
| 05/11/2000 | WO2000026224A2 Novel macrolide antibiotics |
| 05/11/2000 | WO2000026216A1 Pyrazolopyridine derivatives as selective cox-2 inhibitors |
| 05/11/2000 | WO2000026212A1 Chromenone and chromanone derivatives as integrin inhibitors |
| 05/11/2000 | WO2000026208A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity |
| 05/11/2000 | WO2000026206A1 Method for producing luteolin and luteolin derivatives |
| 05/11/2000 | WO2000026205A1 Aromatic derivatives and iron complexes thereof for the use as normalising agents of the iron level |
| 05/11/2000 | WO2000026203A1 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 05/11/2000 | WO2000026202A1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 05/11/2000 | WO2000026201A1 Benzoylpyridazines |
| 05/11/2000 | WO2000026192A1 Substituted 2-phenylbenzimidazoles, the production thereof and their use |
| 05/11/2000 | WO2000026186A1 Pyrrolidine compounds and medicinal utilization thereof |
| 05/11/2000 | WO2000025805A1 Vascular endothelial growth factor-like protein from orf virus nz2 binds and activates mammalian vegf receptor-2 |
| 05/11/2000 | WO2000025804A2 A method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failure |
| 05/11/2000 | WO2000025791A1 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
| 05/11/2000 | WO2000025788A1 Inhibitors of prenyl-protein transferase |
| 05/11/2000 | WO2000025787A1 Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same |
| 05/11/2000 | WO2000025786A1 Heterocyclic potassium channel inhibitors |
| 05/11/2000 | WO2000025776A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 05/11/2000 | WO2000025774A1 Benzamide potassium channel inhibitors |
| 05/11/2000 | WO2000025770A1 Carbocyclic potassium channel inhibitors |
| 05/11/2000 | WO2000025764A2 Compositions for the treatment and prevention of cardiovascular diseases |